GlassScriptPhysician profile
Steve A Velazquez
NPI 1912678624
$3,998.17
in general payments reported to CMS, 2019-2025
13 companies · $809 in 2025
The $809 reported for 2025 was more than what 76% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $240 · 2022: $862 · 2023: $1,263 · 2024: $824 · 2025: $809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,815 · Education: $80.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,815.23 |
| Education | $80.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $773.10 | 2022-2025 | Invega Sustenna, Invega Trinza |
| Otsuka America Pharmaceutical, INC. | $676.87 | 2022-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Lundbeck LLC | $492.48 | 2022-2025 | Abilify Maintena, Rexulti |
| Teva Pharmaceuticals USA, INC. | $454.64 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| E.R. Squibb & Sons, L.L.C. | $345.65 | 2024-2025 | Cobenfy |
| Alkermes, INC. | $311.31 | 2022-2025 | Aristada, Lybalvi, Vivitrol |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $293.66 | 2022-2025 | Caplyta |
| Neurocrine Biosciences, INC. | $260.05 | 2023-2024 | Ingrezza |
| Abbvie INC. | $182.99 | 2022-2023 | |
| Axsome Therapeutics, INC. | $142.60 | 2024-2025 | Auvelity |
| Indivior INC. | $23.73 | 2022 | |
| Intuitive Surgical, INC. | $21.32 | 2022 | |
| Idorsia Pharmaceuticals US INC | $19.77 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Velazquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.